Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1636

Similar articles for PubMed (Select 8364927)

3.

Anti-tumor efficacy of an anti-epidermal-growth-factor-receptor monoclonal antibody and its F(ab')2 fragment against high- and low-EGFR-expressing carcinomas in nude mice.

Tosi E, Valota O, Negri DR, Adobati E, Mazzoni A, Meazza R, Ferrini S, Colnaghi MI, Canevari S.

Int J Cancer. 1995 Sep 4;62(5):643-50.

PMID:
7665239
4.

Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, Mendelsohn J.

J Natl Cancer Inst. 1993 Aug 18;85(16):1327-33.

PMID:
8340945
5.

Regulation of epidermal growth factor receptor in NIH3T3/HER14 cells by antireceptor monoclonal antibodies.

Fan Z, Mendelsohn J, Masui H, Kumar R.

J Biol Chem. 1993 Oct 5;268(28):21073-9.

6.

Epidermal growth factor receptor as a target for therapy with antireceptor monoclonal antibodies.

Mendelsohn J.

J Natl Cancer Inst Monogr. 1992;(13):125-31. Review.

PMID:
1389685
7.
8.

Dual mode of action of a human anti-epidermal growth factor receptor monoclonal antibody for cancer therapy.

Bleeker WK, Lammerts van Bueren JJ, van Ojik HH, Gerritsen AF, Pluyter M, Houtkamp M, Halk E, Goldstein J, Schuurman J, van Dijk MA, van de Winkel JG, Parren PW.

J Immunol. 2004 Oct 1;173(7):4699-707.

10.

Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.

Rodeck U, Williams N, Murthy U, Herlyn M.

J Cell Biochem. 1990 Oct;44(2):69-79.

PMID:
2250044
11.
12.

Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.

Ciardiello F, Damiano V, Bianco R, Bianco C, Fontanini G, De Laurentiis M, De Placido S, Mendelsohn J, Bianco AR, Tortora G.

J Natl Cancer Inst. 1996 Dec 4;88(23):1770-6.

13.
15.

Anti-epidermal growth factor receptor monoclonal antibodies affecting signal transduction.

Reins HA, Steinhilber G, Freiberg B, Anderer FA.

J Cell Biochem. 1993 Feb;51(2):236-48.

PMID:
8382707
16.

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

Negri DR, Tosi E, Valota O, Ferrini S, Cambiaggi A, Sforzini S, Silvani A, Ruffini PA, Colnaghi MI, Canevari S.

Br J Cancer. 1995 Oct;72(4):928-33.

17.

Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.

Liu Y, Zheng M, Lai Z, Xiong D, Fan D, Xu Y, Peng H, Shao X, Xu Y, Yang M, Wang J, Liu H, Xie Y, Yang C, Zhu Z.

Cancer Lett. 2004 Mar 18;205(2):143-53.

PMID:
15036646
19.

Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody.

Goldenberg A, Masui H, Divgi C, Kamrath H, Pentlow K, Mendelsohn J.

J Natl Cancer Inst. 1989 Nov 1;81(21):1616-25.

PMID:
2795690
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk